Diet Folate, DNA Methylation and Polymorphisms in Methylenetetrahydrofolate Reductase in Association with the Susceptibility to Gastric Cancer |
Gao, Shang
(Department of Anthropotomy, School of Basic Medicine, Inner Mongolia Medical University)
Ding, Li-Hong (Department of Internal Medicine, Affiliated Hospital, Inner Mongolia Medical University) Wang, Jian-Wei (Department of Anthropotomy, School of Basic Medicine, Inner Mongolia Medical University) Li, Cun-Bao (Department of Biochemical and Molecular Biology, Affiliated Hospital, Inner Mongolia Medical University) Wang, Zhao-Yang (Department of General Surgery, Affiliated Hospital, Inner Mongolia Medical University) |
1 | Munoz N (1994). Is Helicobacter pylori a cause of gastric cancer? An appraisal of the seroepidemiological evidence. Cancer Epidemiol Biomarkers Prev, 3, 445-51. |
2 | Perri F, Cotugno R, Piepoli A, et al (2007). Aberrant DNA methylation in non-neoplastic gastric mucosa of H. pylori infected patients and effect of eradication. Am J Gastroenterol, 102, 1361-71. DOI ScienceOn |
3 | Shen H, Xu Y, Zheng Y, et al (2001). Polymorphisms of 5, 10-methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population: a case-control study. Int J Cancer, 5, 332-6. |
4 | Taylor DN, Blaser MJ (1991). The epidemiology of Helicobacter pylori infection. Epidemiol Rev, 13, 42-59. |
5 | Vollset SE, Igland J, Jenab M, et al (2007). The association of gastric cancer risk with plasma folate, cobalamin, and methylenetetrahydrofolate reductase polymorphisms in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev, 16, 2416-24. DOI ScienceOn |
6 | Wang J, Sasco AJ, Fu C, et al (2008). Aberrant DNA methylation of P16, MGMT, and hMLH1 genes in combination with MTHFR C677T genetic polymorphism in esophageal squamous cell carcinoma. Cancer Epidemiol Biomark Prev, 17, 118-25. DOI ScienceOn |
7 | Zacho J, Yazdanyar S, Bojesen SE, et al (2011). Hyperhomocysteinemia, methylenetetrahydrofolate reductase c.677C>T polymorphism and risk of cancer: cross-sectional and prospective studies and meta-analyses of 75,000 cases and 93,000 controls. Int J Cancer, 128, 644-52. DOI ScienceOn |
8 | Zhao P, Lin F, Li Z, et al (2011). Folate intake, methylenetetrahydrofolate reductase polymorphisms, and risk of esophageal cancer. Asian Pac J Cancer Prev, 12, 2019-23. |
9 | Zuniga-Noriega JR, Velazco-Campos Mdel R, Aguirre-Rodriguez A, et al (2007). C677T polymorphism of the MTHFR gene and the risk of developing distal gastric cancer in a Mexican population. Rev Gastroenterol Mex, 72, 355-8. |
10 | Cui LH, Shin MH, Kweon SS, Kim HN, et al (2010). Methylenetetrahydrofolate reductase C677T polymorphism in patients with gastric and colorectal cancer in a Korean population. BMC Cancer, 10, 236. DOI ScienceOn |
11 | Das PM, Singal R (2004). DNA methylation and cancer. J Clin Oncol, 22, 4632-42. DOI ScienceOn |
12 | DE Cassia Carvalho Barbosa R, DA Costa DM, Cordeiro DE, et al (2012). Interaction of MTHFR C677T and A1298C, and MTR A2756G Gene Polymorphisms in Breast Cancer Risk in a Population in Northeast Brazil. Anticancer Res, 32, 4805-11. |
13 | Eichholzer M, Luthy J, Moser U, et al (2001). Folate and the risk of colorectal, breast and cervix cancer: the epidemiological evidence. Swiss Med Wkly, 131, 539-49. |
14 | Galvan-Portillo MV, Cantoral A, Onate-Ocana LF, et al (2009): Gastric cancer in relation to the intake of nutrients involved in onecarbon metabolism among MTHFR 677 TT carriers. Eur J Nutr, 48, 269-76. DOI |
15 | Gius D, Bradbury CM, Sun L, et al (2005). The epigenome as a molecular marker and target. Cancer, 104, 1789-93. DOI ScienceOn |
16 | International Agency for Research on Cancer (2008). Globocan 2008: Stomach Cancer incidence, Mortality and Prevalence Worldwide in 2008. IARC. |
17 | Issa JP (2004). CpG island methylator phenotype in cancer. Nat Rev Cancer, 4, 988-93. DOI ScienceOn |
18 | Jernal A, Siegel R, Ward E, Murray T, et al (2007). Cancer statistics, 2007. CA Cancer J Clin, 57, 43-66. DOI ScienceOn |
19 | Jing C, Huang Z, Duan Y, et al (2012). Folate intake, methylenetetrahydrofolate reductase polymorphisms in association with the prognosis of esophageal squamous cell carcinoma. Asian Pac J Cancer Prev, 13, 647-51. DOI ScienceOn |
20 | La Vecchia C, Negri E, Pelucchi C, Franceschi S (2002). Dietary folate and colorectal cancer. Int J Cancer, 102, 545-7. DOI ScienceOn |
21 | Nakai K, Mitomi H, Alkam Y, et al (2012). Predictive value of MGMT, hMLH1, hMSH2 and BRCA1 protein expression for pathological complete response to neoadjuvant chemotherapy in basal-like breast cancer patients. Cancer Chemother Pharmacol, 69, 923-30. DOI ScienceOn |
22 | Lee KH, Lee JS, Nam JH, et al (2011). Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence. Langenbecks Arch Surg, 396, 1017-26. DOI ScienceOn |
23 | Mason JB (2009). Folate, cancer risk, and the Greek god, Proteus: A tale of two chameleons. Nutr Rev, 67, 206-12. DOI ScienceOn |
24 | Momparler RL, Bovenzi V (2000). DNA methylation and cancer. J Cell Physiol, 183, 145-54. DOI ScienceOn |
25 | Qin JM, Wang XM, Chen B, et al (2008). Study on the ingestion of folate and polymorphism of MTHFR C677T with esophageal cancer in Xinjiang Kazakh. Zhonghua Liu Xing Bing Xue Za Zhi, 29, 30-3. |
26 | Saberi S, Zendehdel K, Jahangiri S, et al (2012). Impact of Methylenetetrahydrofolate Reductase C677T Polymorphism on the Risk of Gastric Cancer and Its Interaction with Helicobacter pylori Infection. Iran Biomed J, 16, 179-84. |
27 | Chen HTK, Graubard BI, Heineman EF, et al (2002). Nutrient intakes and adenocarcinoma of the esophagus and distal stomach. Nutr Cancer, 42, 33-40. DOI ScienceOn |
28 | Chen J, Huang ZJ, Duan YQ, et al (2012). Aberrant DNA Methylation of P16, MGMT, and hMLH1 Genes in combination with MTHFR C677T Genetic Polymorphism and Folate Intake in Esophageal Squamous Cell Carcinoma. Asian Pac J Cancer Prev, 13, 5303-6. DOI ScienceOn |
![]() |